A 73-year-old never smoking woman was admitted for exertional dyspnoea to the Respiratory Medicine Section of our hospital in June 2014. The patient's past clinical history revealed systemic arterial hypertension, persistent atrial fibrillation, non-insulin dependent diabetes, hypothyroidism, and hypercholesterolemia. She was taking in treatment with acenocoumarol and metformin. The patient had progressive exercise dyspnoea (NYHA class II) and ankle swelling since 2011. She had been diagnosed with interstitial lung disease with pulmonary hypertension (PAPs of 60 mmHg by transthoracic echocardiography) and hypoxemic respiratory insufficiency. She was referred to our hospital following further worsening of dyspnoea and reduction in exercise tolerance despite long-term oxygen therapy (1 L/min). At admission, she had dyspnoea on minor activities (modified Medical Research CouncilmMRC = 3, NYHA class III), cyanosis, increased respiratory rate (22 breaths/min), and ankle swelling. She had systemic pressure at lower limits of normality (105/ 65 mmHg) and a BMI of 28 (158 cm, 71 kg). At physical examination, fine crackles were audible at both lung bases. She had low (54 mmHg) arterial oxygen tension in oxygen therapy with 1 L/min with CO 2 tension of 50 mmHg, in a framework of compensated respiratory acidosis (HCO 3 -33 mmHg). No alterations of serum electrolytes were found. We got sufficient correction of hypoxia (PaO 2 63 mmHg) by increasing flow oxygen support at 3 L/min with a modest increase of hypercapnia (PaCO 2 54 mmHg). The chest radiograph showed increased cardiac size, bulging of the second arch on the left mediastinal border compatible with enlargement of the pulmonary artery common trunk (Fig. 1) . No signs of pulmonary congestion were observed. The electrocardiogram showed atrial fibrillation with average ventricular rate of 77 beats per minute, intraventricular conduction delay, and right axial deviation. Transthoracic echocardiography showed severe tricuspidal regurgitation with TAPSE (tricuspid annular plane systolic excursion) of 15 mm, PAPs of 70 mmHg, right and left atrial enlargement, interventricular septum paradoxical movement, inferior vena cava dilatation with no change on inspiration, mild pericardial effusion, and normal size and wall thickness of the left ventricle, without alteration on the segmental kinesis. Cardiac ejection fraction was preserved (61%). No diastolic relaxation abnormalities were detected. E/A ratio [early transmitral flow (E) and the late flow with atrial contraction (A)] was 0.8 and the ratio E/e 0 [early filling velocity on transmitral Doppler (E) with the early relaxation velocity on tissue Doppler (e 0 )] was 7. Only mild mitral regurgitation was described. Calcification of the cusps of the aortic valve with normal opening was described. Aortic valve peak gradient was 22 mmHg.
Case presentation Elena Torricelli, Chiara Cresci A 73-year-old never smoking woman was admitted for exertional dyspnoea to the Respiratory Medicine Section of our hospital in June 2014. The patient's past clinical history revealed systemic arterial hypertension, persistent atrial fibrillation, non-insulin dependent diabetes, hypothyroidism, and hypercholesterolemia. She was taking in treatment with acenocoumarol and metformin. The patient had progressive exercise dyspnoea (NYHA class II) and ankle swelling since 2011. She had been diagnosed with interstitial lung disease with pulmonary hypertension (PAPs of 60 mmHg by transthoracic echocardiography) and hypoxemic respiratory insufficiency. She was referred to our hospital following further worsening of dyspnoea and reduction in exercise tolerance despite long-term oxygen therapy (1 L/min). At admission, she had dyspnoea on minor activities (modified Medical Research CouncilmMRC = 3, NYHA class III), cyanosis, increased respiratory rate (22 breaths/min), and ankle swelling. She had systemic pressure at lower limits of normality (105/ 65 mmHg) and a BMI of 28 (158 cm, 71 kg). At physical examination, fine crackles were audible at both lung bases. She had low (54 mmHg) arterial oxygen tension in oxygen therapy with 1 L/min with CO 2 tension of 50 mmHg, in a framework of compensated respiratory acidosis (HCO 3 -33 mmHg). No alterations of serum electrolytes were found. We got sufficient correction of hypoxia (PaO 2 63 mmHg) by increasing flow oxygen support at 3 L/min with a modest increase of hypercapnia (PaCO 2 54 mmHg). The chest radiograph showed increased cardiac size, bulging of the second arch on the left mediastinal border compatible with enlargement of the pulmonary artery common trunk (Fig. 1) . No signs of pulmonary congestion were observed. The electrocardiogram showed atrial fibrillation with average ventricular rate of 77 beats per minute, intraventricular conduction delay, and right axial deviation. Transthoracic echocardiography showed severe tricuspidal regurgitation with TAPSE (tricuspid annular plane systolic excursion) of 15 mm, PAPs of 70 mmHg, right and left atrial enlargement, interventricular septum paradoxical movement, inferior vena cava dilatation with no change on inspiration, mild pericardial effusion, and normal size and wall thickness of the left ventricle, without alteration on the segmental kinesis. Cardiac ejection fraction was preserved (61%). No diastolic relaxation abnormalities were detected. E/A ratio [early transmitral flow (E) and the late flow with atrial contraction (A)] was 0.8 and the ratio E/e 0 [early filling velocity on transmitral Doppler (E) with the early relaxation velocity on tissue Doppler (e 0 )] was 7. Only mild mitral regurgitation was described. Calcification of the cusps of the aortic valve with normal opening was described. Aortic valve peak gradient was 22 mmHg.
We decided to treat the patient with furosemide 20 mg iv TID, oxygen therapy (3 L/min) with a partial clinical improvement, reduction on ankle swelling, and dyspnea reduction (NHYA II/III).
Functional assessment was performed when the patient was already out of the acute phase. At pulmonary function tests, static and dynamic lung volumes were within normal limits, while carbon monoxide diffusion was markedly reduced (54% of predicted value). The in 6-min walked distance was 240 m (58% of predicted value). Nadir haemoglobin desaturation during the test was 85%.
Differential diagnosis
Federico Lavorini, Chiara Cresci, Chiara Arcangeli, Edoardo Cavigli, Mariaelena Occhipinti, Massimo Pistolesi A CT scan at lung window setting (Fig. 2 ) showed mosaic perfusion with reduced vessel size within areas of decreased attenuation (sharply marginated and with a geographic distribution) and bilateral areas of air-space consolidations with subpleural distribution. The initial diagnosis of pulmonary hypertension secondary to interstitial lung disease was discarded on the basis of the imaging findings. The CT scan at mediastinal window setting showed multiple mediastinal lymphadenomegalies (up to 24 mm), cardiomegaly with enlargement of right ventricle and right atrium and rotation of cardiac axis towards left, pericardial effusion, and enlargement of the common trunk of the pulmonary artery (52 mm) extending to both main pulmonary arteries. Since at end-expiratory CT, no significant air-trapping was detected, the mosaic perfusion pattern was attributed to a vascular disorder. The combination of mosaic perfusion with enlargement of pulmonary arteries and right cardiac chambers is consistent with pulmonary hypertension. Air-space consolidations were peripheral and wedge-shaped, and had central lucencies, no air-bronchogram, and hazy ground-glass borders. These CT findings are not specific, as they can be seen in pulmonary infarctions as well as in infections and neoplasms [1] . The patient denied consent to contrast medium injection and underwent perfusion lung scanning showing non-segmental perfusion defects [2] , due to impressions on the lung of the enlarged central cardiovascular structures, not compatible with chronic thromboembolic pulmonary hypertension (Fig. 3) . The lack of segmental perfusion defects excludes the hypothesis of pulmonary infarctions at CT, due to the high sensitivity of lung perfusion scanning [3] . However, laboratory tests did not show parameters of inflammation, like CRP and leukocytosis, and the patient temperature was normal.
The cardiac catheterization confirmed severe pre-capillary hypertension with a mean pulmonary arterial pressure of 46 mmHg, with systolic pulmonary artery pressure (SPAP) of 72 mmHg, diastolic PAP of 34 mmHg, and pulmonary wedge pressure of 14 mmHg. The right atrial pressure was 10 mmHg and the right ventricular systolic pressure was 72/010 mmHg. Cardiac output was 3.7 L/ min. Cardiac Index was 2.1 L/min/m 2 . Pulmonary vascular resistance was as high as 9.7 Wood units. The transpulmonary pressure gradient (TPG) was as high as 32 mmHg and the diastolic pressure gradient was 20 mmHg. No evidence of intracardiac shunts was found by oximetry measurements within the cardiac chambers. Mixed venous oxygen saturation (SvO 2 ) was equal to 65%. Although the pulmonary wedge pressure was at the upper limit of normal (14 mmHg), many clinical factors can affect this value, including the age of patient, the past clinical history of arterial hypertension, the persistent atrial fibrillation, and the non-insulin-dependent diabetes. Moreover, all other hemodynamic parameters reliable to distinguish pre-capillary pulmonary hypertension (i.e., diastolic pressure gradient and transpulmonary pressure gradient) were consistent with a pre-capillary PH form.
Based on pulmonary function, echocardiographic, imaging, and hemodynamic data, we excluded groups 2, 3, and 4 of PH [4, 5] (Table 1 ). The differential diagnosis was then limited to groups 1 and 5 of PH.
Final diagnosis and management
Edoardo Cavigli, Chiara Arcangeli, Chiara Cresci, Francesca Bigazzi, Massimo Pistolesi Anti-nuclear antibodies, anti-extractable nuclear antigen, cANCA, pANCA autoantibodies, rheumatoid factor, serology for HIV, HCV, and HBV were normal. These findings excluded any specific and associated cause of pulmonary arterial hypertension (PAH). The patient denied any intake of drugs or toxins; thus, induced PAH from these agents was excluded. No signs of schistosomiasis infection were found. At ultrasound, no signs of portal hypertension were seen. Her history was negative for familial pulmonary arterial hypertension. Therefore, all causes of group 1 for PAH were excluded. The blood tests showed normal thyroid function and regular ACE and chitotriosidase serum levels. We also excluded metabolic, haematological, and systemic disorders. Therefore, pulmonary veno-occlusive disease (PVOD) or idiopathic PAH were left in the differential diagnosis. However, CT scan did not show the typical findings for PVOD (i.e., smoothly thickened interlobular septa, small central pulmonary veins, pleural effusion, and centrilobular ground-glass opacities), and at the same time, CT images were not compatible with idiopathic PAH (usually without lung parenchymal changes). Due to the patient's poor health conditions, bronchoscopy, and lung biopsy were not performed. Thus, we concluded that this could be a case of PH with unclear mechanisms. The patient was treated with sildenafil 20 mg three times per day planning to re-evaluate the patient after 1 month follow-up to ascertain the need of any combined therapy.
Despite an initial improvement with a significant reduction of dyspnoea and an improvement in exercise 
Discussion
Massimo Pistolesi, Edoardo Cavigli, Mariaelena Occhipinti, Elena Torricelli, Chiara Cresci, Chiara Arcangeli
The diagnosis of PAH requires a clinical hypothesis based on symptoms and physical examination and review of a comprehensive set of investigations to confirm the haemodynamic criteria, the aetiology, and the haemodynamic severity of the condition. This is particularly important to identify patients with idiopathic PAH, or who may have more than one cause of PAH. The cause of PAH should be identified according to the clinical classification following the diagnostic algorithm proposed by the ESC/ ERS Guidelines in 2015 [4, 5] (Table 1) . According to the diagnostic algorithm, we excluded the most common groups of PH: group 2, group 3, and subsequently group 4.
First, group 2 PH was ruled out by transthoracic echocardiography, heart catheterization, CXR, and chest CT scan. Transthoracic echocardiography did not show signs consistent with left heart failure. Cardiac ejection fraction was preserved (61%), without systolic or diastolic relaxation abnormalities, or a significant mitral regurgitation. The CXR ruled out signs of pulmonary venous hypertension, such as interstitial septal thickening and alveolar filling, cuffing of bronchi and vessels, increased size, density, and blurring of the hilar vessels, loss of sharpness of the hemi-diaphragms, widening of pleural fissures, and blood flow redistribution toward the apical regions. The right heart catheterization was consistent with a pre-capillary form of PH. Echocardiography as well as chest CT scan excluded the presence of anatomic congenital anomalies.
Second, group 3 PH was ruled out by the CT scan. It did not show findings consistent with interstitial lung disease or chronic obstructive lung disease. No interstitial septal thickening, traction bronchiectasis, honeycombing, emphysema, or bronchial thickening were present. The few parenchymal consolidations with peripheral distribution seen in this patient were not sufficient to explain the severe pulmonary hypertension as measured at heart catheterization.
Third, group 4 PH was ruled out by the lung perfusion scan. It did not show segmental perfusion defects Finally, we suspected either a form of idiopathic PAH or a case of PVOD, which are rare causes of PAH [6] . Their differential diagnosis is crucial, as PVOD has a worse prognosis with potentially life-threatening abrupt pulmonary oedema [6, 7] . PVOD shares many similarities with idiopathic PAH, in terms of clinical features and haemodynamic characteristics [8] . Their clinical presentation is non-specific, mainly characterised by dyspnoea, and they cannot be distinguished neither hemodynamically [9] or by perfusion lung scan [9, 10] . However, PVOD has lower arterial oxygen tension, lower nadir oxygen saturation during exercise, and lower diffusing capacity for carbon monoxide and occult pulmonary haemorrhage with haemosiderin-laden macrophages at bronchoalveolar lavage [8, [11] [12] [13] . A definitive diagnosis of PVOD necessitates surgical lung biopsy, but patients with PVOD often present with advanced disease and surgical lung biopsy is contra-indicated, as it is invasive and at high risk for bleeding, pneumothorax, worsening of respiratory distress, and death [8] . However, high-resolution chest CT scan can help in differential diagnosis, as reported in recent articles [6, 11, 14] . In consideration of the high negative predictive value of CT scan, the absence of septal thickening and of centrilobular ground-glass opacities excludes the diagnosis of PVOD in the reported case. On the other hand, a diagnosis of idiopathic PAH cannot be formulated, as in idiopathic PAH imaging, findings are generally limited to the enlargement of the right and left pulmonary arteries without evidence of pulmonary parenchymal abnormalities. Although the main limitation of this case diagnosis is the absence of an autopsy, so we could not formulate a definite diagnosis.
In conclusion, an accurate diagnosis is essential for an appropriate management of PH. Recent multidisciplinary classification algorithms are of great help to correctly classify patients with PH. However, as shown in the reported case, there may be clinical presentations of PH that cannot be assigned to one of the forms of PH listed in the comprehensive clinical classification of pulmonary hypertension proposed by the ESC/ERS Guidelines in 2015.
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